Ferguson, Gary T <br/><br/>
Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS study.  [electronic resource] 

 -  The European respiratory journal  09 2018 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1399-3003 
<br/><br/><label>Standard No.: </label>10.1183/13993003.01334-2018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Aged<br/>Bronchodilator Agents--administration & dosage<br/>Budesonide--administration & dosage<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Forced Expiratory Volume--drug effects<br/>Formoterol Fumarate--administration & dosage<br/>Humans<br/>Internationality<br/>Male<br/>Metered Dose Inhalers<br/>Middle Aged<br/>Pulmonary Disease, Chronic Obstructive--drug therapy<br/>Treatment Outcome